Description
Product Description
Octreotide Acetate is a synthetic octapeptide analog of natural somatostatin, developed to provide prolonged biological stability and enhanced receptor selectivity. Compared with native somatostatin, octreotide demonstrates a significantly longer half-life and improved resistance to enzymatic degradation, making it a widely studied peptide in endocrinology, oncology, and pharmacological research.
Structurally, Octreotide Acetate retains the key pharmacophoric residues responsible for somatostatin receptor binding while eliminating unstable peptide segments. This modification allows octreotide to selectively interact with somatostatin receptor subtypes, particularly SSTR2 and SSTR5, which are abundantly expressed in neuroendocrine tissues and tumor models.
In research environments, Octreotide Acetate is extensively applied in studies related to hormone secretion regulation, tumor growth inhibition, receptor signaling pathways, and peptide drug delivery systems. Its ability to modulate growth hormone, insulin, glucagon, and gastrointestinal peptide secretion has positioned it as a reference compound in endocrine and metabolic investigations.
Octreotide Acetate is also an important tool in receptor binding assays, radiolabeling studies, and imaging agent development, particularly in neuroendocrine tumor research models. Its stable peptide structure supports reliable formulation, storage, and experimental reproducibility.
For formulation science, octreotide acetate is widely used to evaluate lyophilization behavior, excipient compatibility, peptide stability, and sustained-release delivery technologies. These studies contribute to the optimization of long-acting peptide dosage forms and injectable delivery systems.
To ensure consistency in experimental results, Octreotide Acetate is supplied with strict batch control, high purity standards, and comprehensive analytical validation.
Product Specifications
| Item | Description |
|---|---|
| Product Name | Octreotide Acetate |
| Synonyms | SMS 201-995; Octreotide acetate salt |
| CAS Number | 83150-76-9 |
| Molecular Formula | C49H66N10O10S2 · C2H4O2 |
| Molecular Weight | 1019.24 g/mol (free base approx. 1019.2) |
| Amino Acid Sequence | D-Phe-Cys-Phe-D-Trp-Lys-Thr-Cys-Thr-ol |
| Peptide Type | Synthetic cyclic octapeptide |
| Form | Lyophilized powder |
| Purity | ≥99% (HPLC) |
| Strength Options | 2 mg, 5 mg, 10 mg, 20 mg |
| Appearance | White to off-white powder |
| Identity Verification | HPLC, MS |
| Solubility | Soluble in water and dilute acids |
| Packaging | Sterile glass vial |
| Storage Condition | -20°C, protected from light |
| Intended Use | Research use only |
Applications
Octreotide Acetate is widely applied in:
Endocrine hormone regulation studies
Neuroendocrine tumor research
Somatostatin receptor binding assays
Peptide stability and degradation studies
Drug delivery and sustained-release formulation research
Radiolabeled imaging agent development
Pharmacokinetic and pharmacodynamic modeling
Signal transduction pathway analysis
Its stability and receptor selectivity make Octreotide Acetate a key reference peptide in peptide drug research.

Packaging
Supplied in sterile, sealed glass vials with nitrogen protection. Customized labeling, secondary packaging, and batch coding are available for bulk research supply.

Storage & Transportation
Store at -20°C in a dry, light-protected environment. During transportation, cold-chain protection is recommended to maintain peptide stability and structural integrity.
Inquiry & Technical Consultation
For COA, MS spectra, HPLC chromatograms, formulation data, or batch-specific technical documents of Octreotide Acetate, please submit your inquiry via the contact form below. Our technical team will provide comprehensive support for your research requirements.
Disclaimer
This product is intended for research use only. It is not approved for human or veterinary consumption. All experimental applications must comply with applicable regulatory and institutional guidelines.






Reviews
There are no reviews yet.